Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Reason Magazine (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

New York's Governor Seems Indifferent to the Health Consequences of a Steep Tax on Nicotine Pouches

% of readers think this story is Fact. Add your two cents.


New York Gov. Kathy Hochul against a background of nicotine pouches and dollar signs | Midjourney/Anthony Behar/Sipa USA/Newscom

By pushing a 75 percent wholesale tax on nicotine pouches, New York State Budget Director Blake Washington says, Gov. Kathy Hochul is trying to address “a public health concern.” That rationale is absurd on its face, since this tax would sharply raise the cost of a nicotine product that is far less hazardous than cigarettes, perversely discouraging smokers from making a switch that could save their lives.

Hochul, who seems determined to portray a money grab as a benevolent intervention, is either oblivious or indifferent to the health consequences of taxing nicotine patches at the same rate as cigarettes. “We see it as a distinction without a difference,” Washington told reporters in January.

That position ignores the huge difference between inhaling tobacco smoke, which contains myriad toxins and carcinogens, and orally absorbing nicotine from a pouch placed between the lip and gums. Hochul’s framing also contradicts what the Food and Drug Administration (FDA) said four days before the end of the Biden administration, when it authorized the marketing of Zyn nicotine pouches in two doses and 10 flavors.

That decision was based on the FDA’s determination that “the new products offer greater benefits to population health than risks.” The data, said Matthew Farrelly, director of the Office of Science at the FDA’s Center for Tobacco Products, “show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products.”

Nicotine pouches contain “substantially lower amounts of harmful constituents than cigarettes,” the FDA noted. They therefore offer “a lower-risk alternative for adults who smoke cigarettes.”

How much lower? To give you a sense of the difference, the Royal College of Physicians estimates that “the hazard to health” from e-cigarettes, which likewise do not contain tobacco or burn anything but do require inhalation, “is unlikely to exceed 5% of the harm from smoking tobacco.”

Nicotine pouches “contain far, far fewer harmful constituents compared to traditional tobacco products,” notes Mary Hrywna, a tobacco control specialist at the Rutgers School of Public Health. The FDA’s Zyn decision implicitly acknowledged that nicotine pouches are “much safer than cigarettes,” says Ray Niaura, a professor at New York University’s School of Global Public Health.

Does that sound like “a distinction without a difference”? Washington conceded that cigarettes pose a much more serious cancer risk than nicotine pouches do but added that “there’s an addictive property to both,” which is “really the thrust behind” the proposed tax.

Seriously? The central problem with cigarettes is not their addictiveness, which would be of much less moment if smokers did not face a substantial danger of premature death. Other things being equal, a nicotine habit that promises to dramatically reduce that hazard surely counts as a big improvement.

The Hochul administration also argues that a hefty tax will deter teenagers from using nicotine pouches. But according to the National Youth Tobacco Survey, just 1.6 percent of middle and high school students reported past-month use of nicotine pouches last year, down from 1.8 percent in 2024.

Since selling nicotine pouches to anyone younger than 21 is already illegal, enforcing that rule seems like a more sensible way to prevent underage consumption than imposing a new financial burden on adults. That is especially true given the evidence that nicotine pouches are an appealing alternative for adults who smoke.

A 2025 study, for instance, found that “daily nicotine pouch use is most prevalent among adults who recently quit using another tobacco product.” A study considered by the FDA found that a quarter of people who initially used Zyn in combination with cigarettes, smokeless tobacco, or both had switched entirely to the nicotine pouches within 10 weeks.

A randomized trial reported in 2024 found that nicotine pouches were especially effective at reducing cigarette consumption among low-income smokers, who would be disproportionately affected by Hochul’s tax. These findings suggest that levy would undermine public health in the name of protecting it.

© Copyright 2026 by Creators Syndicate Inc.

The post New York’s Governor Seems Indifferent to the Health Consequences of a Steep Tax on Nicotine Pouches appeared first on Reason.com.


Source: https://reason.com/2026/04/01/new-yorks-governor-seems-indifferent-to-the-health-consequences-of-a-steep-tax-on-nicotine-pouches/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login